Loading...

PODCAST

Medical News Updates

Welcome to "Medical News Updates," the go-to channel for anyone eager to understand complex medical news in a straightforward, simplified manner. Our mission is to break down the latest health studies and medical news into easy-to-digest information that makes sense to everyone, especially those without a medical background.What We Offer:Weekly Medical News: Stay updated with the latest happenings in the medical world, explained in plain language.Exploring Health Studies: We translate complex data

education courses

All Episodes

6:55

Stopping a GLP-1, a Blood Test Worth a Second Look,...

Medical News Updates ·

2026/09/16

This week: how quickly weight returns after stopping semaglutide or tirzepatide, why a borderline normal haemoglobin may deserve a closer look, twelve month results for automated insulin delivery in type 1 diabetes, why the testosterone dose matters for heart rhythm, and what two million people can and cannot tell us about drinks and mood.In this episode.Weight regain after stopping a GLP-1, from a pooled analysis of six randomised trials in Endocrinology, Diabetes and Metabolism.Borderline low

en

6:44

Statins After Seventy, and a Sick Day Rule Worth...

Medical News Updates ·

2026/09/06

This week: a large trial finds statins cut heart attacks and strokes in healthy over seventies but do not prevent dementia or disability, a Scandinavian study of more than 280,000 people pins down who is most at risk of ketoacidosis on flozin medicines, semaglutide and tirzepatide enter the European heart failure guidelines, immune cells appear to remember obesity for years, and four medical bodies issue joint autumn vaccine advice.statins, atorvastatin, STAREE trial, primary prevention, healthy

en

6:24

A Sensor That Sees DKA Coming, Statins After 70, and...

Medical News Updates ·

2026/09/01

This week in plain English: the first wearable that tracks glucose and ketones together, the STAREE trial on statins for healthy over 70s, why missed blood pressure pills erase their benefit, the first RAS targeted drug for pancreatic cancer, and new guidelines on cardiac rehab.Source:FDA press release, 25 Aug 2026, Libre Duo 10 Day authorization: https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-wearable-device-continuously-monitors-both-ketone-levels-and-blood-sugarHealio,

en

4:00

FDA Authorizes Libre Duo: Continuous Glucose and...

Medical News Updates ·

2026/08/30

The FDA has authorized Libre Duo, a wearable sensor designed to monitor glucose and ketones continuously for people with diabetes aged two years and older.This Medical News Update explains how the system works, why rising ketones matter, its potential role in detecting diabetic ketoacidosis risk, and the important limitations patients and caregivers should understand. Continuous monitoring supports, but does not replace, a written sick-day plan, backup ketone testing, or urgent medical care when

en

6:19

A Lettuce Outbreak, a Cholesterol Pill, and What...

Medical News Updates ·

2026/07/22

This week, a nationwide Cyclospora outbreak tied to fast food lettuce, the first pill form of a powerful cholesterol drug, new data on activity levels for people on GLP-1 medications, a possible link between hormone exposure and thyroid cancer, and an update on the Ebola outbreak in Central Africa. Plain English, no hype.

en

4:23

TRUE METRIX Glucose Meter Safety Alert

Medical News Updates ·

2026/06/08

The FDA warns TRUE METRIX meters can show one E-5 code for two very different problems. Don't stop testing — but arrange a backup meter when you can.A safety alert for anyone using a TRUE METRIX blood glucose meter. The FDA has flagged a serious problem — the same "E-5" error code can mean either dangerously high glucose OR a simple test strip error. Those need opposite responses, and getting it wrong can be dangerous. We explain what the FDA is recommending and, importantly, what NOT to do.In this

en

4:31

Omnipod Pod Correction: What Users Should Check

Medical News Updates ·

2026/06/05

The FDA posted an Omnipod correction — some Pods may under-deliver insulin. Not every Pod is affected. Check your lot numbers and keep a backup plan.If you use an Omnipod insulin pump, here's an important safety notice — explained calmly. On May 26, 2026, the FDA posted a voluntary Medical Device Correction from Insulet because certain Pods may leak insulin and deliver less than intended. This is a correction, not a blanket recall — most Pods aren't affected — but everyone using Omnipod should check

en

4:20

Dexcom G7 Sensor Recall: Check These Two Lot Numbers

Medical News Updates ·

2026/06/01

Two lots of Dexcom G7 sensors were stolen before destruction and resold. Check lot numbers 1725204004 and 1725069002. Here's what to do.A safety alert for anyone using a Dexcom G7 continuous glucose monitor. On May 26, 2026, Dexcom revealed that sensors marked for destruction were stolen and resold through unauthorized channels. This is NOT a warning about every G7 sensor — it affects two specific lot numbers. We walk through exactly what to check and what to do.In this episode:• The two affected

en

4:28

Fatty Liver May Be a Heart Warning

Medical News Updates ·

2026/05/29

A Mass General Brigham study links fatty liver to a 69% higher relative risk of major heart events. Why your liver is talking to your heart.Fatty liver disease — now called MASLD — is everywhere. As many as 1 in 3 American adults have some degree of it, often without knowing. For years, doctors treated it as a liver problem. A new Mass General Brigham study, using cardiac CT scans of 3,637 patients from the PROMISE trial, shows we've been thinking about it wrong. People with fatty liver had more

en

4:01

What Happens When You Stop Tirzepatide?

Medical News Updates ·

2026/05/25

The SURMOUNT-MAINTAIN trial answers what happens after you stop Mounjaro or Zepbound — and offers a lower-dose maintenance option that mostly held weight off.Tirzepatide — the drug you know as Mounjaro for diabetes and Zepbound for weight loss — has produced some of the biggest weight-loss numbers we have ever seen. But everyone asks the same question: what happens when you stop? A new trial called SURMOUNT-MAINTAIN, published in The Lancet, finally gives us a clean answer. People who continued the

en

3:58

Spotting Type 1 Diabetes in Kids Before Symptoms

Medical News Updates ·

2026/05/22

A German JAMA study screened 220,000+ children for early type 1 diabetes during normal pediatric visits—catching it years before symptoms appear.For most families, type 1 diabetes shows up out of nowhere — sometimes as a child rushed to the emergency room in diabetic ketoacidosis. But a huge new study from Germany, published in JAMA, suggests we can do much better. Pediatricians in Bavaria screened more than 220,000 children for early-stage type 1 diabetes during routine office visits — catching the

en

2:55

Medical News Update The Breakthrough Wegovy Weight...

Medical News Updates ·

2026/05/12

FDA Approves Wegovy Weight-Loss Pill: What to Know About Oral SemaglutideThis episode explains the first FDA-approved GLP-1 weight-loss drug in pill form: a once-daily oral semaglutide tablet (Wegovy pill) approved on December 22, 2025, with a U.S. launch in early January 2026. It clarifies that Rybelsus is also oral semaglutide but is only approved for type 2 diabetes, making Wegovy the first oral GLP-1 specifically approved for chronic weight management. Results from the 71-week OASIS 4 trial

en

3:15

Retatrutide, a Powerful New Weight Loss Drug in the...

Medical News Updates ·

2026/05/04

Retatrutide Phase 3 Results: Major A1C Drops and 16.8% Weight Loss in Type 2 DiabetesThis Medical News Update covers late-stage trial results for retatrutide, an investigational weight-loss and diabetes drug from Eli Lilly. On March 19, 2026, Lilly announced positive topline findings from the phase 3 TRANSCEND-T2D-1 trial in adults with type 2 diabetes, showing A1C reductions of 1.7% to 2.0% depending on dose and average weight loss of 16.8% at the 12 mg dose. The script explains retatrutide’s

en

2:47

Why Ozempic Sometimes Doesn't Work

Medical News Updates ·

2026/04/28

Why Ozempic Doesn’t Work for Everyone: The DNA ClueThis episode explains why Ozempic and similar weight-loss drugs don’t work the same for everyone, highlighting a Stanford University study published in April 2026. Researchers found that about 10% of people carry variants in a single gene affecting the enzyme PAM, which helps activate the body’s natural GLP-1 hormone—the system these medications rely on. With a sluggish PAM “switch,” GLP-1 may not be properly activated, which could help explain why

en

4:58

How Metabolic Health Shapes the Brain, Blood Vessels,...

Medical News Updates ·

2026/02/07

New Insights on Metabolic Health: Protect Your Brain and HeartIn this week's Medical News Update, we delve into recent research revealing how metabolic health impacts more than we realize. Key studies show that weight and blood pressure may contribute to dementia and heart issues, while redefining obesity could change our health landscape. We also highlight the effects of different types of fat on our blood vessels, the implications of post-meal blood sugar spikes on Alzheimer's risk, and the

en

5:13

High Dose Flu Vaccine Better Protection for Older...

Medical News Updates ·

2026/02/03

In this episode of Medical News Update, we discuss a recent study from Denmark examining the efficacy of high-dose inactivated influenza vaccines in adults aged 65 and older, particularly those with diabetes. The study reveals that high-dose vaccines lead to fewer cardiorespiratory and cardiovascular hospitalizations compared to standard-dose vaccines. While the exact benefits vary, the findings suggest that a high-dose approach is beneficial for older adults, especially those with long-standing

en

4:25

BMI, blood pressure, and vascular dementia link

Medical News Updates ·

2026/01/23

In this podcast episode, we discussWhat “vascular-related dementia” means and why blood flow mattersWhy Mendelian randomisation strengthens causal inference, and where it can misleadThe size of the BMI association and what the odds ratios implyHow much of the link may run through blood pressureWhat listeners can do now: knowing your numbers and seeking realistic supportSources mentionedThe Journal of Clinical Endocrinology and Metabolism (online publication: 22 January 2026)Endocrine Society press

en

2:45

Medical News update: Smart Insulin and Dual‑Hormone...

Medical News Updates ·

2025/11/15

In this episode of Medical News Update, we explore innovative advancements in blood glucose regulation, focusing on smart insulin and dual-hormone therapy. Researchers at Indiana University School of Medicine have developed a fusion protein that combines insulin and glucagon, offering potential stability and effectiveness in managing blood sugar levels. Early animal studies show promise, but more research is needed before human clinical trials. Join us to learn how this could revolutionise type 1

en

2:33

Semaglutide and Vision Loss: What You Need to Know

Medical News Updates ·

2025/09/10

In today's episode, we discuss an important alert from the WHO regarding semaglutide medicines like Ozempic, Rybelsus, and Wegovy, which are used for type 2 diabetes and weight management. A rare but serious side effect called non-arteritic anterior ischemic optic neuropathy (NAY-on), leading to sudden vision loss, has been linked to these drugs. We review what the European Medicines Agency has found, the risks involved, and what patients should do if they experience vision changes. Awareness and

en

2:57

Artificial Sweeteners and the Ageing Brain

Medical News Updates ·

2025/09/05

Can diet sodas and sugar-free foods speed up brain ageing? A new study from the ELSA-Brasil cohort, published in Neurology, finds that artificial sweeteners are linked to faster memory and cognitive decline, especially in midlife adults and those with diabetes. In this episode, we break down the study, its strengths and limitations, and what it means for everyday dietary choices.

en

31 results

Similar Podcasts

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Psychology in Everyday Life: The Psych Files

Michael Britt

Bedtime Safari

Bedtime History

The Day with Geoff Barton

The Day News and Media Ltd